Research Article

Efficacy of Transdermal Oxybutynin in the Treatment of Overactive Bladder Syndrome: Does It Make Sense Using It in 2017?

Table 3

Changes 3D from baseline in the 3 DVD tool at 12 months of treatment with OXY-TDS (naive/nonnaive patients).

3 DVDNaive ()
mean (SD)
Nonnaive ()
mean (SD)
Diff (95% CI) value

DUF (episodes/day)7.07 (1.8)6.9 (1.5)0.4 (−0.7; 1.3)0.341
NUF (episodes/night)0.87 (0.7)0.7 (0.8)0.0 (−3.0; 0.7)0.411
UF/24 hours (episodes/day)8.0 (2.1)7.6 (1.7)6.3 (−0.4; 1.7)0.298
Maximum UV (ml)444.6 (486.1)302.1 (83.1)24.1 (−41.7; 100.0)0.461
Nocturnal UV (ml)112.6 (84.9)143.83 (168.9)−31.2 (−135.9; 73.5)0.550
Mean UV (ml)205.5 (54.9)191.0 (NA)14.5 (−180.6; 209.6)0.828
Urgency (episodes/day)1.5 (2.1)1.5 (1.2)0.5 (−0.9; 1.0)0.892
Urgency grade1.8 (1.3)2.5 (1.3)−0.7 (−1.3; 0.0)0.071
UUI (episodes/day)0.2 (0.5)0.6 (1.0)0.0 (−0.3; 0.0)0.328
SUI (episodes/day)0.0 (0.0)0.2 (0.6)0.0 (0.0; 0.0)0.110
Pad/underwear changes (number/day)0.6 (1.0)0.8 (1.1)0.0 (−0.6; 0.0)0.044
Liquid intake/24 h (ml)1484.73 (613.5)1439.0 (481.9)45.7 (−326.4; 417.1)0.805
Urine output/24 h (ml)1609.17 (446.6)1457.89 (347.2)151.3 (−115.5; 418.0)0.258
Nocturnal urine output (ml)167.77 (138.3)185.26 (228.2)−17.5 (−162.6; 127.6)0.808

3 DVD: 3-day voiding diary; DUF: daytime urinary frequency; NUF: night-time urinary frequency; SD: standard deviation; SUI: stress urinary incontinence; UF/24 h: 24-hour urinary frequency (total number of episodes/24 hours); UUI: urge urinary incontinence. values: Student’s t-test or Wilcoxon signed rank test. Change: mean difference, or Hodges-Lehman estimator of location shift.